STP, modélisation et pharmacogénétique
mercredi 12 juin 2024
Sessions parallèles
Sessions parallèles
•
S42
•
16h00
>
17h30
•
STP, modélisation et pharmacogénétique
•
Amphi E
Sessions parallèles
Modérateurs : Peggy GANDIA (Toulouse), Olivier Mathieu (Montpellier)
Conférence invitée
16h00 Suivi thérapeutique pharmacologique des médicaments inhalés : un STP à inventer ? - Stanislas GRASSIN-DELYLE (Suresnes)
Communications orales
•
42
•
CO-037 - Association Between Olanzapine Plasma Concentrations and Treatment Response: A Systematic Review, Meta-analysis and Individual Participant Data Meta-analysis
>
Z.
Zoubir
DJERADA
•
143
•
CO-038 - The GRIK4 rs1954787 polymorphism is associated with clinical improvement in antidepressant-treated depressed patients: results from a prospective cohort and meta-analysis
>
K.
Kenneth
Chappell
•
191
•
CO-039 - Dosage regimen of ceftobiprole in critically ill patients: proposal for a dosage regimen abacus
>
C.
Camille
MANE
•
214
•
CO-040 - Cefepime concentration-toxicity relationship: first results from the Toxepim study
>
S.
Sébastien
Lalanne
•
232
•
CO-041 - Therapeutic drug monitoring of beta-lactamins in intensive care: the ADAPT-ICU study
>
P.
Pierre
Martin
•
259
•
CO-042 - Subcutaneous and intravenous ceftriaxone show similar PK/PD in older patients
>
H.
Héloïse
Fauchon
|